BosSTENT ImpLant to trEat debilitatiNg Pulse-synchronous Tinnitus (NCT07070089)
🩺 Plain-English Summary (8th-Grade Level)
This study is evaluating the safety and clinical performance of the BosSTENT, a new stent designed specifically for treating pulse-synchronous tinnitus due to venous sinus stenosis. The study will evaluate the long-term safety of the BosSTENT as well as its impact on the severity of pulse-synchronous tinnitus.
Who can join: Review the eligibility criteria below.
Location: The Ottawa Hospital — Ottawa, Canada
Age range: 18 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (6 Sites)
- The Ottawa Hospital — Ottawa, Canada
- Unity Health Toronto - St. Michael's Hospital — Toronto, Canada
- CHU de Bordeaux — Bordeaux, France
- CHU Montpelier — Montpellier, France
- Hôpital de la Pitié Salpêtrière — Paris, France
- CHRU Tours — Tours, France
📞 Contact the Study Coordinator
Phone: (949) 810-0055
Email: info@sonorousnv.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Pulsatile Tinnitus clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.